Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion.

Gupta MK, Polisetty RV, Sharma R, Ganesh RA, Gowda H, Purohit AK, Ankathi P, Prasad K, Mariswamappa K, Lakshmikantha A, Uppin MS, Sundaram C, Gautam P, Sirdeshmukh R.

Sci Rep. 2019 Jul 29;9(1):10986. doi: 10.1038/s41598-019-47360-9.

2.

Identification of urinary proteins potentially associated with diabetic kidney disease.

Marikanty RK, Gupta MK, Cherukuvada SV, Kompella SS, Prayaga AK, Konda S, Polisetty RV, Idris MM, Rao PV, Chandak GR, Dakshinamurty KV.

Indian J Nephrol. 2016 Nov-Dec;26(6):434-445.

3.

Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers.

Polisetty RV, Gautam P, Gupta MK, Sharma R, Gowda H, Renu D, Shivakumar BM, Lakshmikantha A, Mariswamappa K, Ankathi P, Purohit AK, Uppin MS, Sundaram C, Sirdeshmukh R.

Sci Rep. 2016 Jun 1;6:26882. doi: 10.1038/srep26882.

4.

Transcriptomic and Proteomic Data Integration and Two-Dimensional Molecular Maps with Regulatory and Functional Linkages: Application to Cell Proliferation and Invasion Networks in Glioblastoma.

Gupta MK, Jayaram S, Reddy DN, Polisetty RV, Sirdeshmukh R.

J Proteome Res. 2015 Dec 4;14(12):5017-27. doi: 10.1021/acs.jproteome.5b00765. Epub 2015 Oct 23.

PMID:
26464075
5.

Towards developing biomarkers for glioblastoma multiforme: a proteomics view.

Jayaram S, Gupta MK, Polisetty RV, Cho WC, Sirdeshmukh R.

Expert Rev Proteomics. 2014 Oct;11(5):621-39. doi: 10.1586/14789450.2014.939634. Epub 2014 Aug 13. Review.

PMID:
25115191
6.

Heterogeneous nuclear ribonucleoproteins and their interactors are a major class of deregulated proteins in anaplastic astrocytoma: a grade III malignant glioma.

Polisetty RV, Gautam P, Gupta MK, Sharma R, Uppin MS, Challa S, Ankathi P, Purohit AK, Renu D, Harsha HC, Pandey A, Sirdeshmukh R.

J Proteome Res. 2013 Jul 5;12(7):3128-38. doi: 10.1021/pr400339h. Epub 2013 Jun 6.

PMID:
23741984
7.

Secretome analysis of Glioblastoma cell line--HNGC-2.

Gupta MK, Polisetty RV, Ramamoorthy K, Tiwary S, Kaur N, Uppin MS, Shiras A, Sirdeshmukh R.

Mol Biosyst. 2013 Jun;9(6):1390-400. doi: 10.1039/c3mb25383j. Epub 2013 Mar 13.

PMID:
23483059
8.

Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis.

Gautam P, Nair SC, Gupta MK, Sharma R, Polisetty RV, Uppin MS, Sundaram C, Puligopu AK, Ankathi P, Purohit AK, Chandak GR, Harsha HC, Sirdeshmukh R.

PLoS One. 2012;7(9):e46153. doi: 10.1371/journal.pone.0046153. Epub 2012 Sep 28.

9.

LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions.

Polisetty RV, Gautam P, Sharma R, Harsha HC, Nair SC, Gupta MK, Uppin MS, Challa S, Puligopu AK, Ankathi P, Purohit AK, Chandak GR, Pandey A, Sirdeshmukh R.

Mol Cell Proteomics. 2012 Jun;11(6):M111.013565. doi: 10.1074/mcp.M111.013565. Epub 2012 Jan 4.

10.

Glioblastoma cell secretome: analysis of three glioblastoma cell lines reveal 148 non-redundant proteins.

Polisetty RV, Gupta MK, Nair SC, Ramamoorthy K, Tiwary S, Shiras A, Chandak GR, Sirdeshmukh R.

J Proteomics. 2011 Sep 6;74(10):1918-25. doi: 10.1016/j.jprot.2011.05.002. Epub 2011 May 11.

PMID:
21601021

Supplemental Content

Loading ...
Support Center